Pretreatment of ADSCs with resveratrol-functionalized selenium nanoparticles alleviate CCl4-induced liver fibrosis in mice
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2026-08 · 1872 (6) · 168290
DOI: 10.1016/j.bbadis.2026.168290 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2026-08. Verfasst von Shuangjuan Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, 471023, Henan, China. Hauptthemen laut MEDLINE: Selenium, Resveratrol, Nanoparticles, Mesenchymal Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Henan Province Natural Science Foundation.
Abstract (Originalsprache)
BACKGROUND Liver fibrosis (LF) is an abnormal repair reaction after chronic liver injury. Currently, adipose-derived mesenchymal stem cells (ADSCs) are widely used in the treatment of liver diseases. However, the therapeutic effect of ADSCs is affected by the damaged microenvironment. In this study, a resveratrol-functionalized nano‑selenium (Res@SeNPs) formulation was prepared to investigate whether Res@SeNPs pretreatment can enhance the therapeutic effect and alter the potential mechanism of ADSCs in carbon tetrachloride (CCl4) -induced LF in mice. METHODS Res@SeNPs were prepared and ADSCs pretreated with Res@SeNPs were cocultured with CCl4-injured BRL-3A cells in vitro. In vivo, ADSCs pretreated with Res@SeNPs were injected into the tail vein of a CCl4-induced LF mouse model. RESULTS Res@SeNPs were successfully prepared. In vitro, after coculture with BRL-3A cells, the function of damaged BRL-3A cells was improved. In vivo, Res@SeNPs-pretreated ADSCs effectively alleviated liver function damage and fibrosis in mice with LF. This may be related to the inhibition of oxidative stress, the reduction in apoptosis and the inhibition of the activation of the apoptosis signal-regulated kinase 1/c-Jun N-terminal kinase/p38 mitogen-activated protein kinase (ASK1/JNK/p38) pathway. CONCLUSION Our study suggested that Res@SeNPs pretreatment can enhance the therapeutic effect of ADSCs on LF in mice, and in vivo findings indicated the potential mechanism of ADSCs, providing new ideas for the treatment of LF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, 471023, Henan, China.
- College of Animal Science and Technology, Henan University of Science and Technology, Luoyang, 471023, Henan, China. Electronic address: yumeiliu@haust.edu.cn.
Förderung
- Henan Province Natural Science Foundation
Zitieren
APA
Liu, S., Zhang, Z., Luo, D., Wen, F., Zhu, X., Chen, X., Zhang, T., Feng, J., Hou, L., & Liu, Y. (2026). Pretreatment of ADSCs with resveratrol-functionalized selenium nanoparticles alleviate CCl4-induced liver fibrosis in mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1872(6), 168290. https://doi.org/10.1016/j.bbadis.2026.168290
Vancouver
Liu S, Zhang Z, Luo D, Wen F, Zhu X, Chen X, et al. Pretreatment of ADSCs with resveratrol-functionalized selenium nanoparticles alleviate CCl4-induced liver fibrosis in mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2026;1872(6):168290. doi:10.1016/j.bbadis.2026.168290
BibTeX
@article{Liu2026,
author = {Liu, Shuangjuan and Zhang, Ziqiang and Luo, Dongliu and Wen, Fengyun and Zhu, Xuemin and Chen, Xiaoguang and Zhang, Tianao and Feng, Jingwen and Hou, Leyao and Liu, Yumei},
title = {Pretreatment of ADSCs with resveratrol-functionalized selenium nanoparticles alleviate CCl4-induced liver fibrosis in mice},
journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
year = {2026},
volume = {1872},
number = {6},
pages = {168290},
doi = {10.1016/j.bbadis.2026.168290}
}
EUVIMED